Scholarlink

Abstract <p>Spread of antimicrobial resistance and lack of new antibiotics have brought attention to alternative strategies of combating pathogenic bacteria. One of these strategies takes advantage of the bacteriolytic activity of peptidoglycan hydrolases. The enzymes allow efficient elimination of pathogenic bacteria while preserving the natural microflora. Such enzymes must meet specific criteria of activity, stability, and safety to become efficient enzybiotics. In our previous work (10.1128/spectrum.03546-23), we have created three chimeric enzymes and demonstrated their high efficacy in the elimination of <i>Enterococcus faecalis</i> and <i>Staphylococcus aureus</i>. In this work, we investigated and addressed issues related to the stability and safety of these enzymes. To improve the stability, we engineered the linkers and optimized storage conditions. Moreover, we demonstrated that such enzymes do not have any cytotoxic effects on eukaryotic cells, <i>Danio rerio</i> or <i>Galleria mellonella</i>. We also investigated the prevalence of resistance development, a particularly important feature for new antimicrobials. In conclusion, we here propose efficient, safe, and stable chimeric enzybiotics to eliminate <i>E. faecalis</i> and <i>S. aureus</i>.</p> Key points <p>• <i>Optimized linker design enhances enzyme stability.</i></p> <p>• <i>Generated chimeric lysins do not display cytotoxicity.</i></p> <p>• <i>Chimeras with minimal risk of resistance development&#xa0;were selected.</i></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Enhancing stability and safety of chimeric peptidoglycan hydrolases by linker engineering

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月12日

查看全文
  • Paweł Mitkowski,
  • Elżbieta Jagielska,
  • Małgorzata Korzeniowska nee Wiweger,
  • Marzena Nowacka,
  • Morten Kjos,
  • Christian Kranjec,
  • Izabela Sabała

摘要

Abstract

Spread of antimicrobial resistance and lack of new antibiotics have brought attention to alternative strategies of combating pathogenic bacteria. One of these strategies takes advantage of the bacteriolytic activity of peptidoglycan hydrolases. The enzymes allow efficient elimination of pathogenic bacteria while preserving the natural microflora. Such enzymes must meet specific criteria of activity, stability, and safety to become efficient enzybiotics. In our previous work (10.1128/spectrum.03546-23), we have created three chimeric enzymes and demonstrated their high efficacy in the elimination of Enterococcus faecalis and Staphylococcus aureus. In this work, we investigated and addressed issues related to the stability and safety of these enzymes. To improve the stability, we engineered the linkers and optimized storage conditions. Moreover, we demonstrated that such enzymes do not have any cytotoxic effects on eukaryotic cells, Danio rerio or Galleria mellonella. We also investigated the prevalence of resistance development, a particularly important feature for new antimicrobials. In conclusion, we here propose efficient, safe, and stable chimeric enzybiotics to eliminate E. faecalis and S. aureus.

Key points

• Optimized linker design enhances enzyme stability.

• Generated chimeric lysins do not display cytotoxicity.

• Chimeras with minimal risk of resistance development were selected.